VasculoMedics Overview

  • Founded
  • 2007
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

VasculoMedics General Information


Developer of zinc finger transcription. The company provides an epigenetic platform to develop orally available small molecular inhibitors of zinc finger transcription factors. Its prime focus is on dermatology, ocular diseases and women's health.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Primary Office
  • 37 Neillian Crescent
  • Jamaica Plain
  • Boston, MA 02130
  • United States
+1 (617) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

VasculoMedics Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore VasculoMedics‘s full profile, request access.

Request a free trial